Abstract Background Single-cell genome sequencing provides high-resolution details of the clonal genomic modifications that occur during cancer initiation, progression, and ongoing evolution as patients undergo treatment. One limitation of current single-cell sequencing strategies is a suboptimal capacity to detect all classes of single-nucleotide and structural variants in the same cells. Results Here we present a new approach for determining comprehensive variant profiles of single cells using a microfluidic amplicon-based strategy to detect structural variant breakpoint sequences instead of using relative read depth to infer copy number changes. This method can reconstruct the clonal architecture and mutational history of a malignancy us...
SummaryTumor heterogeneity presents a challenge for inferring clonal evolution and driver gene ident...
AbstractThe purpose of the study was to explore the feasibility of a protocol for the isolation and ...
Most cancers evolve from a single founder cell through a series of clonal expansions that are driven...
Tumours are heterogeneous populations of cells that evolve dynamically in response to selective pres...
Although all cells in a human body are descendant from a single cell –i.e. the zygote– the genetic c...
Single cell genomics offers an unprecedented resolution to interrogate genetic heterogeneity in a pa...
Next generation sequencing (NGS) technology provides researchers an opportunity to study cancer gen...
Next generation sequencing (NGS) technology provides researchers an opportunity to study cancer gen...
The nature and pace of genome mutation is largely unknown. Because standard methods sequence DNA fro...
<div><p>Somatic mosaicism occurs throughout normal development and contributes to numerous disease e...
Emerging ultra-low coverage single-cell DNA sequencing (scDNA-seq) technologies have enabled high re...
Abstract Background Querying cancer genomes at single-cell resolution is expected to provide a power...
<div><p>Next-generation sequencing has been used to infer the clonality of heterogeneous tumor sampl...
Genomic analysis provides insights into the role of copy number variation in disease, but most metho...
© 2017 Dr. Marek CmeroCancers arise from single progenitor cells that acquire mutations, eventually ...
SummaryTumor heterogeneity presents a challenge for inferring clonal evolution and driver gene ident...
AbstractThe purpose of the study was to explore the feasibility of a protocol for the isolation and ...
Most cancers evolve from a single founder cell through a series of clonal expansions that are driven...
Tumours are heterogeneous populations of cells that evolve dynamically in response to selective pres...
Although all cells in a human body are descendant from a single cell –i.e. the zygote– the genetic c...
Single cell genomics offers an unprecedented resolution to interrogate genetic heterogeneity in a pa...
Next generation sequencing (NGS) technology provides researchers an opportunity to study cancer gen...
Next generation sequencing (NGS) technology provides researchers an opportunity to study cancer gen...
The nature and pace of genome mutation is largely unknown. Because standard methods sequence DNA fro...
<div><p>Somatic mosaicism occurs throughout normal development and contributes to numerous disease e...
Emerging ultra-low coverage single-cell DNA sequencing (scDNA-seq) technologies have enabled high re...
Abstract Background Querying cancer genomes at single-cell resolution is expected to provide a power...
<div><p>Next-generation sequencing has been used to infer the clonality of heterogeneous tumor sampl...
Genomic analysis provides insights into the role of copy number variation in disease, but most metho...
© 2017 Dr. Marek CmeroCancers arise from single progenitor cells that acquire mutations, eventually ...
SummaryTumor heterogeneity presents a challenge for inferring clonal evolution and driver gene ident...
AbstractThe purpose of the study was to explore the feasibility of a protocol for the isolation and ...
Most cancers evolve from a single founder cell through a series of clonal expansions that are driven...